Losartan vs Tofacitinib
Losartan vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Losartan and Tofacitinib.
Mechanism of Action
Losartan: Angiotensin II receptor type 1 antagonist.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Losartan β 2 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Losartan β C22H23ClN6O; Tofacitinib β C16H20N6O.
Molecular Weight: Losartan β 422.9200 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Losartan β Small molecule; Tofacitinib β Small molecule.